Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 385 of 1,261
  1. US 10836702

    Compositions and methods comprising resveratrol

    Biocogent, LLC · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted
  2. US 10835597

    Compositions and methods for stabilizing flaviviruses with improved formulations

    Takeda Vaccines, Inc. · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted
  3. US 10835595

    PD1 and PDL1 antibodies and vaccine combinations and use of same for immunotherapy

    Inovio Pharmaceuticals, Inc. · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted
  4. US 10835609

    Hydrogels for delivery of therapeutic compounds

    The Board of Regents of the University of Texas System · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted
  5. US 10835574

    Modulators of complement activity

    RA PHARMACEUTICALS, INC. · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted
  6. US 10837961

    Molecular imprinted colored silica beads

    The Board of Regents of the University of Texas System · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted
  7. US 10835514

    Dry powder inhaler compositions of 7-azoniabicyclo[2.2.1]heptane derivatives

    THERON PHARMACEUTICALS, INC. · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted
  8. US 10835541

    Tablet

    Takeda Pharmaceutical Company Limited · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted
  9. US 10835495

    Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same

    W.R. Grace & Co.-Conn. · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted
  10. US 10837016

    Modulation of huntingtin expression

    Ionis Pharmaceuticals, Inc. · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted
  11. US 10836827

    Antibodies specific to glycosylated PD-L1 and methods of use thereof

    The Board of Regents of the University of Texas System · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted
  12. US 10836789

    Inhibitors of glucocorticoid receptor

    ORIC PHARMACEUTICALS, INC. · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted
  13. CA 3135097

    COMBINAISON PHARMACEUTIQUE COMPRENANT DE LA TRAZODONE POUR LE TRAITEMENT DE LA DOULEUR NEUROPATHIQUE

    ACRAF [IT] · Granted Nov 12, 2020 · Expires Nov 7, 2040

    granted
  14. US 2020353106

    Stable, concentrated radionuclide complex solutions

    ADVANCED ACCELERATOR APPLICATIONS ITALY SRL [IT] · Granted Nov 12, 2020 · Expires Nov 7, 2040

    granted
  15. US 10828265

    Formulations of propranolol and analogs as an amorphous melt or ionic liquid for transdermal drug delivery

    The Regents of the University of California · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  16. US 10829544

    Human antibodies to Ebola virus glycoprotein

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  17. US 10829461

    3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

    Valo Early Discovery, Inc. · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  18. US 10829438

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  19. US 10828364

    Method for reducing a myeloid derived suppressor cell population with cationic lipid vaccine compositions

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SEC. OF THE DEPT. OF HEALTH AND HUMAN SERVICES · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  20. US 10828280

    Glucocorticoid receptor modulators to treat pancreatic cancer

    Corcept Therapeutics Incorporated · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  21. US 10829752

    Bacterial toxins and uses thereof as Ras specific proteases for treating cell proliferation diseases and disorders

    Northwestern University · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  22. US 10828250

    Topical formulation

    LIMEWAY PHARMA DESIGN LIMITED · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  23. US 10829795

    Method for rapid in vitro synthesis of glycoproteins via recombinant production of N-glycosylated proteins in prokaryotic cell lysates

    Northwestern University · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  24. US 10829486

    Isoxazole derivatives as FXR agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.